Subgroup Analyses Based on Liver Metastases and the Number of Metastatic Sites from the Mpact Phase III Trial of Nab-Paclitaxel Plus Gemcitabine Vs Gemcitabine Alone for Metastatic Pancreatic Cancer | Publicación